← FDA Drug Approvals (Drugs@FDA)

MONTELUKAST SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2012-08-03

Drug application

FDA Application #
ANDA201522
Application type
Abbreviated New Drug Application (Generic)
Brand name
MONTELUKAST SODIUM
Generic name
Montelukast Sodium
Active ingredients
MONTELUKAST SODIUM
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
CHARTWELL MOLECULAR
First approval
2012-08-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown